{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:54:04Z","timestamp":1790855644522,"version":"4.1.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00c3\u00bcrkiye Bilimsel ve Teknolojik Arastirma Kurumu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00809","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T04:19:56Z","timestamp":1589861996000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":66,"title":["CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS"],"prefix":"10.3389","volume":"11","author":[{"given":"Merve","family":"\u00c7ebi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hacer","family":"Durmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikret","family":"Aysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berker","family":"\u00d6zkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem Engin","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"\u00c7akar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Hocaoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metin","family":"Mercan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel P.","family":"Yent\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melih","family":"T\u00fct\u00fcnc\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vildan","family":"Yayla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Akan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6ner","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye\u015fim","family":"Parman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcher","family":"Saruhan-Direskeneli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1212\/01.wnl.0000254620.45529.97","article-title":"Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis","volume":"68","author":"Deymeer","year":"2007","journal-title":"Neurology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2353\/ajpath.2007.070240","article-title":"Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status","volume":"171","author":"Leite","year":"2007","journal-title":"Am J Pathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1212\/01.WNL.0000041625.41937.FF","article-title":"AChR phosphorylation and indirect inhibition of AChR function in seronegative MG","volume":"59","author":"Plested","year":"2002","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/ene.13300","article-title":"Multiple antibody detection in \u2018seronegative' myasthenia gravis patients","volume":"24","author":"Hong","year":"2017","journal-title":"Eur J Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12016-016-8558-3","article-title":"Thymic germinal centers and corticosteroids in myasthenia gravis: an immunopathological study in 1035. cases and a critical review","volume":"52","author":"Truffault","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S1474-4422(03)00306-5","article-title":"Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets","volume":"2","author":"Vincent","year":"2003","journal-title":"Lancet Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"7868","DOI":"10.4049\/jimmunol.177.11.7868","article-title":"Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia","volume":"177","author":"Le Panse","year":"2006","journal-title":"J Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.4049\/jimmunol.179.8.5099","article-title":"Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation","volume":"179","author":"Haynes","year":"2007","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/eji.200636486","article-title":"The germinal center response is impaired in the absence of T cell-expressed CXCR5","volume":"37","author":"Arnold","year":"2007","journal-title":"Eur J Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.4049\/jimmunol.179.9.5886","article-title":"Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration","volume":"179","author":"Kuchen","year":"2007","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"8180","DOI":"10.4049\/jimmunol.179.12.8180","article-title":"Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells","volume":"179","author":"Bryant","year":"2007","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3389\/fimmu.2018.01637","article-title":"T follicular helper cells in autoimmune disorders","volume":"9","author":"Gensous","year":"2018","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","article-title":"Human blood CXCR5+CD4+ T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion","volume":"34","author":"Morita","year":"2011","journal-title":"Immunity"},{"key":"B17","doi-asserted-by":"publisher","first-page":"827480","DOI":"10.1155\/2012\/827480","article-title":"Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis","volume":"2012","author":"Ma","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e75319","DOI":"10.1371\/journal.pone.0075319","article-title":"Circulating TFH subset distribution is strongly affected in lupus patients with an active disease","volume":"8","author":"Le Coz","year":"2013","journal-title":"PLoS ONE"},{"key":"B19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/annrheumdis-2018-EWRR2019.31","article-title":"Circulating follicular helper T cells are increased in systemic sclerosis and promote plasmablast differentiation through the IL-21 pathway which can be inhibited by ruxolitinib","volume":"78","author":"Ricard","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.4049\/jimmunol.1400775","article-title":"IL-21 Is a central memory T cell\u2013associated cytokine that inhibits the generation of pathogenic Th1\/17 effector cells","volume":"193","author":"Kastirr","year":"2014","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jneuroim.2012.12.001","article-title":"Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis","volume":"256","author":"Luo","year":"2013","journal-title":"J Neuroimmunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.4049\/jimmunol.1500725","article-title":"Augmentation of circulating follicular helper t cells and their impact on autoreactive B cells in myasthenia gravis","volume":"197","author":"Zhang","year":"2016","journal-title":"J Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s12035-014-8985-1","article-title":"Intrathymic Tfh\/B cells interaction leads to ectopic GCs formation and anti-AChR antibody production: central role in triggering MG occurrence","volume":"53","author":"Zhang","year":"2016","journal-title":"Mol Neurobiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/(SICI)1097-4598(199705)20:5<543::AID-MUS2>3.0.CO;2-9","article-title":"Cytokines and the pathogenesis of myasthenia gravis","volume":"20","author":"Zhang","year":"1997","journal-title":"Muscle Nerve"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0123546","DOI":"10.1371\/journal.pone.0123546","article-title":"Differential cytokine changes in patients with myasthenia gravis with antibodies against AChR and MuSK","volume":"10","author":"Yilmaz","year":"2015","journal-title":"PLoS ONE"},{"key":"B27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/mus.22070","article-title":"Increased serum interleukin-17 levels in patients with myasthenia gravis","volume":"44","author":"Roche","year":"2011","journal-title":"Muscle Nerve"},{"key":"B28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1365-3083.2012.02703.x","article-title":"T helper type 17 cells expand in patients with myasthenia-associated thymoma","volume":"76","author":"Wang","year":"2012","journal-title":"Scand J Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/cei.12272","article-title":"Serum cytokine and chemokine profiles in patients with myasthenia gravis","volume":"176","author":"Uzawa","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.4049\/jimmunol.1501339","article-title":"Autoreactive T cells from patients with myasthenia gravis are characterized by elevated IL-17, IFN-\u03b3, and GM-CSF and diminished IL-10 production","volume":"196","author":"Cao","year":"2016","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1084\/jem.20011629","article-title":"In vitro generation of interleukin 10\u2013producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by t helper type 1 (Th1)\u2013 and Th2-inducing cytokines","volume":"195","author":"Barrat","year":"2002","journal-title":"J Exp Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"684","DOI":"10.4049\/jimmunol.1800697","article-title":"High-dose IL-2 skews a glucocorticoid-driven IL-17+IL-10+ memory CD4+T cell response towards a single IL-10\u2013producing phenotype","volume":"202","author":"Mann","year":"2018","journal-title":"J Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e51982","DOI":"10.1371\/journal.pone.0051982","article-title":"Inhibition of aberrant circulating tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus","volume":"7","author":"Feng","year":"2012","journal-title":"PLoS ONE"},{"key":"B34","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/rheumatology\/kex455","article-title":"Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease","volume":"57","author":"Kubo","year":"2017","journal-title":"Rheumatology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jaut.2013.12.015","article-title":"Both treg cells and tconv cells are defective in the myasthenia gravis thymus: roles of IL-17 and TNF-\u03b1","volume":"52","author":"Gradolatto","year":"2014","journal-title":"J Autoimmun"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s10072-017-3009-3","article-title":"High frequencies of circulating Tfh-Th17 cells in myasthenia gravis patients","volume":"38","author":"Yang","year":"2017","journal-title":"Neurol Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/mus.24999","article-title":"CCR9 AND CCR7 are overexpressed in CD4\u2013CD8\u2013 thymocytes of myasthenia gravis patients","volume":"55","author":"Li","year":"2017","journal-title":"Muscle and Nerve"},{"key":"B38","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ana.410270213","article-title":"Increased thymocyte differentiation in myasthenia gravis: A dual-color immunofluorescence phenotypic analysis","volume":"27","author":"Durelli","year":"1990","journal-title":"Ann Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nm.2621","article-title":"Dysregulation of immune homeostasis in autoimmune diseases","volume":"18","author":"Kuchroo","year":"2012","journal-title":"Nat Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cyto.2015.06.011","article-title":"Elevated plasma interleukin-17A in a subgroup of myasthenia gravis patients","volume":"78","author":"Xie","year":"2016","journal-title":"Cytokine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaut.2018.11.005","article-title":"IL-23\/Th17 cell pathway: a promising target to alleviate thymic inflammation maintenance in myasthenia gravis","volume":"98","author":"Villegas","year":"2019","journal-title":"J Autoimmun"},{"key":"B42","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaut.2013.12.005","article-title":"Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis","volume":"52","author":"Yi","year":"2014","journal-title":"J Autoimmun"},{"key":"B43","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/BOR.0b013e328277ef3b","article-title":"Regulation of autoreactive antibodies","volume":"19","author":"Yurasov","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nri2637","article-title":"Dysregulation of germinal centres in autoimmune disease","volume":"9","author":"Vinuesa","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.clim.2019.07.011","article-title":"Unbalanced expression of membrane-bound and soluble inducible costimulator and programmed cell death 1 in patients with myasthenia gravis","volume":"207","author":"Yan","year":"2019","journal-title":"Clin Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/cen3.12319","article-title":"Role of the thymus in autoimmune myasthenia gravis","volume":"7","author":"Berrih-Aknin","year":"2016","journal-title":"Clin Exp Neuroimmunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.4049\/jimmunol.173.6.3816","article-title":"Expression of the glucocorticoid receptor from the 1A promoter correlates with T lymphocyte sensitivity to glucocorticoid-induced cell death","volume":"173","author":"Purton","year":"2004","journal-title":"J Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev.immunol.18.1.309","article-title":"Glucocorticoids in T cell development and function","volume":"18","author":"Ashwell","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1016\/j.celrep.2019.02.108","article-title":"Single-cell resolution and quantitation of targeted glucocorticoid delivery in the thymus","volume":"26","author":"Taves","year":"2019","journal-title":"Cell Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00809\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T04:20:00Z","timestamp":1589862000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00809\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2020.00809"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00809","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,19]]},"article-number":"809"}}